Diode Laser-Assisted Direct Pulp Capping Trial
Effect of Diode Laser Therapy Following Direct Pulp Capping on Postoperative Pain and Dentin Hypersensitivity: A Randomized Controlled Clinical Trial
1 other identifier
interventional
56
1 country
1
Brief Summary
This randomized controlled clinical trial evaluates whether adjunctive 808-nm diode laser therapy after direct pulp capping reduces postoperative pain and dentin hypersensitivity compared with conventional Biodentine treatment. Sixty teeth from fifty-six participants with carious pulp exposure were randomly allocated into two treatment groups. Postoperative pain, dentin hypersensitivity, and 6-month clinical success rates were assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2024
CompletedFirst Submitted
Initial submission to the registry
May 11, 2026
CompletedFirst Posted
Study publicly available on registry
May 18, 2026
CompletedMay 18, 2026
May 1, 2026
2.2 years
May 11, 2026
May 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Dentin Hypersensitivity
Dentin hypersensitivity will be assessed using a cold stimulus test (0-4°C water) and recorded using the Numerical Rating Scale (NRS, 0-10), where higher scores indicate greater sensitivity.
1 month, 3 months, and 6 months after treatment
Postoperative Pain Intensity
Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS, 0-10), where 0 indicates no pain and 10 indicates the worst pain imaginable. Participants will record daily pain scores until complete pain resolution.
Daily until complete pain resolution (up to 7 days after treatment)
Secondary Outcomes (1)
Clinical Success Rate
6 months after treatment
Study Arms (2)
Conventional Biodentine Direct Pulp Capping
ACTIVE COMPARATOREligible teeth received conventional direct pulp capping treatment. After local anesthesia and rubber dam isolation, caries removal and cavity preparation were performed. Hemostasis was achieved using saline-moistened cotton pellets followed by 3% sodium hypochlorite disinfection. Biodentine was placed over the pulp exposure site and the tooth was restored using a selective-etch composite restoration protocol.
Diode Laser-Assisted Biodentine Direct Pulp Capping
EXPERIMENTALEligible teeth received adjunctive 808-nm diode laser therapy during direct pulp capping. After standard cavity preparation, diode laser irradiation was applied for hemostasis and disinfection before placement of Biodentine and definitive composite restoration. The laser protocol included standardized irradiation parameters for pulp hemostasis and cavity disinfection.
Interventions
Biodentine was used as a bioactive tricalcium silicate pulp-capping material placed directly over the exposed pulp tissue following hemostasis and cavity disinfection.
Adjunctive diode laser irradiation was applied for hemostasis and disinfection before Biodentine placement during direct pulp capping.
Eligibility Criteria
You may qualify if:
- Participants aged 10 to 58 years.
- Teeth with pulp exposure caused by caries removal.
- Vital teeth confirmed by clinical pulp vitality tests (cold and heat tests) and radiographic examination.
- No history of spontaneous pain; only mild or tolerable discomfort to cold stimuli.
- Pulp exposure less than 2 mm in diameter.
- Normal radiographic findings with no periapical pathology.
- Bleeding controllable within 10 minutes.
- Written informed consent obtained from participants or legal guardians.
You may not qualify if:
- Pulp exposure caused by trauma or occlusal wear.
- Teeth unsuitable for restoration, including subgingival fractures or vertical root cracks.
- Clinical signs of irreversible pulpitis, abscess, or sinus tract.
- Uncontrollable bleeding after 10 minutes of saline pressure or laser hemostasis.
- Previous use of analgesics before treatment.
- Multiple pulp exposures in the same dental arch.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Odonto-Stomatology, Hue University of Medicine and Pharmacy
Huế, 49000, Vietnam
Related Publications (2)
Yazdanfar I, Barekatain M, Zare Jahromi M. Combination effects of diode laser and resin-modified tricalcium silicate on direct pulp capping treatment of caries exposures in permanent teeth: a randomized clinical trial. Lasers Med Sci. 2020 Oct;35(8):1849-1855. doi: 10.1007/s10103-020-03052-9. Epub 2020 Jun 11.
PMID: 32529588BACKGROUNDYazdanfar I, Gutknecht N, Franzen R. Effects of diode laser on direct pulp capping treatment : a pilot study. Lasers Med Sci. 2015 May;30(4):1237-43. doi: 10.1007/s10103-014-1574-8. Epub 2014 Apr 23.
PMID: 24756324BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anh Chi PHAN, PhD
Hue University of Medicine and Pharmacy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Due to the nature of the intervention, blinding of participants and care providers was not feasible because diode laser application was visible and audible during treatment. However, the outcome assessor responsible for evaluating postoperative pain, dentin hypersensitivity, and clinical follow-up outcomes was blinded to group allocation throughout the study. All assessment forms were coded by participant ID without treatment information, and participants were instructed not to disclose their treatment assignment during follow-up visits.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2026
First Posted
May 18, 2026
Study Start
July 1, 2022
Primary Completion
August 31, 2024
Study Completion
August 31, 2024
Last Updated
May 18, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will be available beginning 6 months following publication and will remain available for 5 years thereafter.
- Access Criteria
- Access will be provided to qualified researchers who submit a methodologically sound proposal for secondary analyses or meta-analysis. Requests should be directed to the corresponding author by email and will be reviewed by the study investigators.
De-identified individual participant data (IPD) underlying the results reported in this study will be shared, including demographic characteristics, postoperative pain scores, dentin hypersensitivity scores, and clinical follow-up outcomes. All personal identifiers will be removed to protect participant confidentiality.